| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.0088 | 1 |